北京抗创联生物制药技术研究

Beijing Kangchuanglian Biopharmaceutical Technology Research Center is a specialized biotechnology research institution based in Beijing, China, focusing on the development of therapeutic biologics. The center provides a comprehensive R&D platform for monoclonal antibodies and recombinant proteins, covering the entire process from gene cloning and cell line construction to large-scale fermentation and purification. Kangchuanglian is recognized for its expertise in biosimilar development and has successfully advanced several candidates into clinical stages through partnerships with major Chinese pharmaceutical firms. Its business model combines internal drug discovery with contract research and technology transfer services to accelerate the industrialization of biopharmaceuticals. The organization plays a key role in the Chinese biotech ecosystem by bridging the gap between laboratory research and commercial manufacturing.